BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

120 related articles for article (PubMed ID: 11552677)

  • 21. Mutagenesis in four candidate heparin binding regions (residues 279-282, 291-304, 390-393, and 439-448) and identification of residues affecting heparin binding of human lipoprotein lipase.
    Ma Y; Henderson HE; Liu MS; Zhang H; Forsythe IJ; Clarke-Lewis I; Hayden MR; Brunzell JD
    J Lipid Res; 1994 Nov; 35(11):2049-59. PubMed ID: 7868983
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Effects of gene mutations in lipoprotein and hepatic lipases as interpreted by a molecular model of the pancreatic triglyceride lipase.
    Derewenda ZS; Cambillau C
    J Biol Chem; 1991 Dec; 266(34):23112-9. PubMed ID: 1744109
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Association of pre-eclampsia with common coding sequence variations in the lipoprotein lipase gene.
    Hubel CA; Roberts JM; Ferrell RE
    Clin Genet; 1999 Oct; 56(4):289-96. PubMed ID: 10636447
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Site-directed mutagenesis of apolipoprotein CII to probe the role of its secondary structure for activation of lipoprotein lipase.
    Shen Y; Lookene A; Zhang L; Olivecrona G
    J Biol Chem; 2010 Mar; 285(10):7484-92. PubMed ID: 20042600
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Two naturally occurring mutations at the first and second bases of codon aspartic acid 156 in the proposed catalytic triad of human lipoprotein lipase. In vivo evidence that aspartic acid 156 is essential for catalysis.
    Ma YH; Bruin T; Tuzgol S; Wilson BI; Roederer G; Liu MS; Davignon J; Kastelein JJ; Brunzell JD; Hayden MR
    J Biol Chem; 1992 Jan; 267(3):1918-23. PubMed ID: 1730727
    [TBL] [Abstract][Full Text] [Related]  

  • 26. [Lipoprotein lipase gene mutations and the risk of cardiovascular diseases in children with obesity].
    Guan YM; Gui YH; Luo FH; Shen SX; Yang Y
    Zhongguo Dang Dai Er Ke Za Zhi; 2010 Mar; 12(3):161-4. PubMed ID: 20350420
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Relative contribution of low-density lipoprotein receptor and lipoprotein lipase gene mutations to angiographically assessed coronary artery disease among French Canadians.
    Gaudet D; Vohl MC; Julien P; Tremblay G; Perron P; Gagné C; Bergeron J; Moorjani S; Després JP
    Am J Cardiol; 1998 Aug; 82(3):299-305. PubMed ID: 9708657
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Common mutations in the lipoprotein lipase gene (LPL): effects on HDL-cholesterol levels in a Chinese Canadian population.
    McGladdery SH; Pimstone SN; Clee SM; Bowden JF; Hayden MR; Frohlich JJ
    Atherosclerosis; 2001 Jun; 156(2):401-7. PubMed ID: 11395037
    [TBL] [Abstract][Full Text] [Related]  

  • 29. The D9N, N291S, and T495G Polymorphisms of the Lipoprotein Lipase Gene Are Not Associated with Cerebral Infarction.
    Ceja-Espíritu G; Delgado-Enciso I; Ramírez-Flores M; Guzmán-Esquivel J; Baltazar-Rodríguez LM
    J Stroke Cerebrovasc Dis; 2016 Apr; 25(4):985-9. PubMed ID: 26853140
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Novel site in lipoprotein lipase (LPL415;-438) essential for substrate interaction and dimer stability.
    Keiper T; Schneider JG; Dugi KA
    J Lipid Res; 2001 Aug; 42(8):1180-6. PubMed ID: 11483618
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Molecular pathobiology of the human lipoprotein lipase gene.
    Murthy V; Julien P; Gagne C
    Pharmacol Ther; 1996; 70(2):101-35. PubMed ID: 8843465
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Human lipoprotein lipase. Analysis of the catalytic triad by site-directed mutagenesis of Ser-132, Asp-156, and His-241.
    Emmerich J; Beg OU; Peterson J; Previato L; Brunzell JD; Brewer HB; Santamarina-Fojo S
    J Biol Chem; 1992 Feb; 267(6):4161-5. PubMed ID: 1371284
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Structure-function relationships of lipoprotein lipase: mutation analysis and mutagenesis of the loop region.
    Henderson HE; Ma Y; Liu MS; Clark-Lewis I; Maeder DL; Kastelein JJ; Brunzell JD; Hayden MR
    J Lipid Res; 1993 Sep; 34(9):1593-602. PubMed ID: 8228642
    [TBL] [Abstract][Full Text] [Related]  

  • 34. 1,1'-bis(anilino)-4-,4'-bis(naphtalene)-8,8'-disulfonate acts as an inhibitor of lipoprotein lipase and competes for binding with apolipoprotein CII.
    Lookene A; Zhang L; Tougu V; Olivecrona G
    J Biol Chem; 2003 Sep; 278(39):37183-94. PubMed ID: 12855707
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Apolipoprotein CII from rainbow trout (Oncorhynchus mykiss) is functionally active but structurally very different from mammalian apolipoprotein CII.
    Shen Y; Lindberg A; Olivecrona G
    Gene; 2000 Aug; 254(1-2):189-98. PubMed ID: 10974550
    [TBL] [Abstract][Full Text] [Related]  

  • 36. The common mutations in the lipoprotein lipase gene in Italy: effects on plasma lipids and angiographically assessed coronary atherosclerosis.
    Arca M; Campagna F; Montali A; Barillà F; Mangieri E; Tanzilli G; Seccareccia F; Campa PP; Ricci G; Pannitteri G
    Clin Genet; 2000 Nov; 58(5):369-74. PubMed ID: 11140837
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Familial lipoprotein lipase deficiency: a case of compound heterozygosity of a novel duplication (R44Kfs*4) and a common mutation (N291S) in the lipoprotein lipase gene.
    Overgaard M; Brasen CL; Svaneby D; Feddersen S; Nybo M
    Ann Clin Biochem; 2013 Jul; 50(Pt 4):374-9. PubMed ID: 23761384
    [TBL] [Abstract][Full Text] [Related]  

  • 38. The D9N, N291S and S447X variants in the lipoprotein lipase (LPL) gene are not associated with Type III hyperlipidemia.
    Evans D; Beil FU
    BMC Med Genet; 2007 Aug; 8():56. PubMed ID: 17727701
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Genetic variant showing a positive interaction with beta-blocking agents with a beneficial influence on lipoprotein lipase activity, HDL cholesterol, and triglyceride levels in coronary artery disease patients. The Ser447-stop substitution in the lipoprotein lipase gene. REGRESS Study Group.
    Groenemeijer BE; Hallman MD; Reymer PW; Gagné E; Kuivenhoven JA; Bruin T; Jansen H; Lie KI; Bruschke AV; Boerwinkle E; Hayden MR; Kastelein JJ
    Circulation; 1997 Jun; 95(12):2628-35. PubMed ID: 9193431
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Characterization of recombinant wild type and site-directed mutations of apolipoprotein C-III: lipid binding, displacement of ApoE, and inhibition of lipoprotein lipase.
    Liu H; Talmud PJ; Lins L; Brasseur R; Olivecrona G; Peelman F; Vandekerckhove J; Rosseneu M; Labeur C
    Biochemistry; 2000 Aug; 39(31):9201-12. PubMed ID: 10924113
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.